Last reviewed · How we verify
Bacopa monnieri
Bacopa monnieri is believed to enhance memory and cognitive function through its antioxidant and anti-inflammatory properties.
Bacopa monnieri is believed to enhance memory and cognitive function through its antioxidant and anti-inflammatory properties. Used for Improving memory and cognitive function in patients with mild cognitive impairment.
At a glance
| Generic name | Bacopa monnieri |
|---|---|
| Sponsor | Q.Mundewadi Ayurvedic Research & Charitable Trust |
| Drug class | Ayurvedic herb |
| Modality | Small molecule |
| Therapeutic area | Neurology |
| Phase | Phase 2 |
Mechanism of action
The exact mechanism of Bacopa monnieri is not fully understood, but it is thought to work by increasing the synthesis of neurotransmitters and improving the functioning of the brain's neural pathways. Additionally, its antioxidant and anti-inflammatory properties may help to protect the brain from damage caused by free radicals and inflammation.
Approved indications
- Improving memory and cognitive function in patients with mild cognitive impairment
Common side effects
- Gastrointestinal upset
Key clinical trials
- The Acute Effects of Onnit Alpha Brain on Cognition and Mood States (NA)
- ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments (PHASE2)
- Study of Bacopa in Gulf War Illness Patients (PHASE2)
- A Clinical Trial to Investigate the Efficacy of a Supplement to Improve and Maintain Cognitive Function and Memory (NA)
- Effect of a Specific Aquaporin-1 Inhibitor on Vascular Oxidative Stress in Healthy Volunteers (NA)
- Effect of Oral Intake of Bacopa Monneiri on Vascular Oxidative Stress (NA)
- The Acute Effects of a Dietary Supplement on Cognitive Performance in Highly Trained Athletes. (NA)
- An Evaluation of the Effects of a Non-Caffeinated Energy Dietary Supplement (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bacopa monnieri CI brief — competitive landscape report
- Bacopa monnieri updates RSS · CI watch RSS
- Q.Mundewadi Ayurvedic Research & Charitable Trust portfolio CI